142 related articles for article (PubMed ID: 34017682)
1. SNHG9, a Papillary Thyroid Cancer Cell Exosome-Enriched lncRNA, Inhibits Cell Autophagy and Promotes Cell Apoptosis of Normal Thyroid Epithelial Cell Nthy-ori-3 Through YBOX3/P21 Pathway.
Wen D; Liu WL; Lu ZW; Cao YM; Ji QH; Wei WJ
Front Oncol; 2021; 11():647034. PubMed ID: 34017682
[TBL] [Abstract][Full Text] [Related]
2. SNHG9, delivered by adipocyte-derived exosomes, alleviates inflammation and apoptosis of endothelial cells through suppressing TRADD expression.
Song Y; Li H; Ren X; Li H; Feng C
Eur J Pharmacol; 2020 Apr; 872():172977. PubMed ID: 32007500
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
4. Silencing of long noncoding RNA RP11-476D10.1 enhances apoptosis and autophagy while inhibiting proliferation of papillary thyroid carcinoma cells via microRNA-138-5p-dependent inhibition of LRRK2.
Zhao Y; Zhao L; Li J; Zhong L
J Cell Physiol; 2019 Nov; 234(11):20980-20991. PubMed ID: 31102261
[TBL] [Abstract][Full Text] [Related]
5. Papillary thyroid cancer-derived exosomes contain miRNA-146b and miRNA-222.
Lee JC; Zhao JT; Gundara J; Serpell J; Bach LA; Sidhu S
J Surg Res; 2015 Jun; 196(1):39-48. PubMed ID: 25819770
[TBL] [Abstract][Full Text] [Related]
6. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of RET gene mediated EGFR signaling pathway on epithelial-mesenchymal transition, proliferation and apoptosis of papillary thyroid carcinoma cells.
Zhao YL; Yuan BQ; Shen GS
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8036-8047. PubMed ID: 32767330
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression.
Zhang H; Cai Y; Zheng L; Zhang Z; Lin X; Jiang N
J Cell Physiol; 2018 Oct; 233(10):6638-6648. PubMed ID: 29319165
[TBL] [Abstract][Full Text] [Related]
9. LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer.
Qin Y; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T; Shao L; Zhang W; Wu C
Endocrine; 2018 Mar; 59(3):555-564. PubMed ID: 29327301
[TBL] [Abstract][Full Text] [Related]
10. Linc00324 promotes the progression of papillary thyroid cancer via regulating Notch signaling pathway.
Wan JF; Wan JY; Dong C; Li L
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6818-6824. PubMed ID: 32633374
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG9 is Downregulated in Non-Small Cell Lung Cancer and Suppressed miR-21 Through Methylation to Promote Cell Proliferation.
Wang D; Cao X; Han Y; Yu D
Cancer Manag Res; 2020; 12():7941-7948. PubMed ID: 32943928
[TBL] [Abstract][Full Text] [Related]
13. SNHG9 promotes Hepatoblastoma Tumorigenesis via miR-23a-5p/Wnt3a Axis.
Feng SG; Bhandari R; Ya L; Zhixuan B; Qiuhui P; Jiabei Z; Sewi M; Ni Z; Jing W; Fenyong S; Ji M; Bhandari R
J Cancer; 2021; 12(20):6031-6049. PubMed ID: 34539877
[No Abstract] [Full Text] [Related]
14. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
Zhang Z; Li SY; Zhang LB
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
[TBL] [Abstract][Full Text] [Related]
15. lncRNA SNHG9 Promotes Cell Proliferation, Migration, and Invasion in Human Hepatocellular Carcinoma Cells by Increasing GSTP1 Methylation, as Revealed by CRISPR-dCas9.
Ye S; Ni Y
Front Mol Biosci; 2021; 8():649976. PubMed ID: 33898523
[TBL] [Abstract][Full Text] [Related]
16. RNA Profile of Cell Bodies and Exosomes Released by Tumorigenic and Non-Tumorigenic Thyroid Cells.
Maggisano V; Capriglione F; Mio C; Bulotta S; Damante G; Russo D; Celano M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338696
[TBL] [Abstract][Full Text] [Related]
17. STAT1-induced upregulation of lncRNA LINP1 promotes cell proliferation and inhibits apoptosis via AMPK signaling pathway in papillary thyroid cancer.
Li HP; Yang TZ; Wei L; Ge YF; Meng QS
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8911-8917. PubMed ID: 32964981
[TBL] [Abstract][Full Text] [Related]
18. SNHG9/miR-199a-5p/Wnt2 Axis Regulates Cell Growth and Aerobic Glycolysis in Glioblastoma.
Zhang H; Qin D; Jiang Z; Zhang J
J Neuropathol Exp Neurol; 2019 Oct; 78(10):939-948. PubMed ID: 31504670
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells.
Zeybek ND; Gulcelik NE; Kaymaz FF; Sarisozen C; Vural I; Bodur E; Canpinar H; Usman A; Asan E
J Endocrinol; 2011 Jul; 210(1):105-15. PubMed ID: 21478229
[TBL] [Abstract][Full Text] [Related]
20. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
